Ionpath
Harris Fienberg serves as an Independent Director on the Board of Directors at Adeptrix Corporation since June 2021 and as President at EBSM Consulting, focusing on biotechnology strategy and operations consulting since August 2020. Fienberg co-founded and led Ionpath Inc. as CEO from 2015 to 2020, where work centered on developing the MIBIscope, a cutting-edge multiplexed tissue imaging technology. Previous experience includes roles as a Postdoctoral Fellow and PhD Candidate at Stanford University School of Medicine, as well as product marketing at Fluidigm Corporation, and a Research Assistant position at Actelion. Educational credentials include a PhD in Microbiology and Immunology from Stanford University, coursework in business strategy and corporate finance, an MSc in Immunology from the University of Basel, and dual bachelor's degrees in Biological Sciences and English from Stanford University.
This person is not in any offices
Ionpath
Ionpath delivers high definition spatial proteomics, revolutionizing tissue imaging and analysis to accelerate discovery and improve human health. Ionpath’s MIBI™ (multiplexed ion beam imaging) Platform breaks through the limitations of traditional IHC, enabling deep understanding of the tissue microenvironment with highly multiplexed quantitative single-cell analysis.